siRNA treatment decreases triglycerides in patients with uncommon condition

.ANALYSIS HIGHLIGHT.19 September 2024.

Plozasiran lowered triglyceride levels through 80% as well as decreased the risk of pancreatitis in clients along with constant chylomicronemia, along with or even without a genetic diagnosis.